IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login
Users Online :1908
Small font sizeDefault font sizeIncrease font size
Navigate Here
     My Preferences 
     Manuscript submission
     Back To Article

Article Access Statistics 

Year : 2021 | Volume:  53 | Issue Number:  3 | Page:  229-233

DRUG WATCH

The effects of empagliflozin on cardiometabolic risk factors in patients with type 2 diabetes: A short-term observational study
Chacko Jithin, Dhandapani Shankar, Jahagiridhar Vidhya, Swaminathan Krishnan

Number of times this article was viewed 980
Number of times this article has been printed  from the site 32
Number of times this article was emailed to others 0
Remarks given by readers [ Read ] 0

 

Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer
Online since 20th July '04
Published by Wolters Kluwer - Medknow